Lilly Broadens Income Eligibility for Patient Assistanc... ( INDIANAPOLIS Aug. 5 /- In...)

Lilly Broadens Income Eligibility for Patient Assistance Programs

Date:8/5/2009

INDIANAPOLIS, Aug. 5 /PRNewswire-FirstCall/ -- In the midst of the down economy, many Americans have seen their financial situations change - for the worse - forcing them to make difficult sacrifices to afford medications or detrimental decisions to stop taking medicines.

On Aug. 1, 2009, Lilly USA adjusted the income eligibility for its most widely used patient assistance programs to allow enrollment of eligible patients with incomes at or less than 300 percent of the U.S. Federal Poverty Level. This is an income eligibility increase from the previous 200 percent Federal Poverty Level. With this change, the income eligibility limit for all Lilly owned or supported patient assistance programs is set at, or above, 300 percent of the current Federal Poverty Level. As an example, the new yearly eligible income limit for a family of two corresponds to approximately $44,000.

"By making these changes, we are addressing a real concern for patients we have heard from in recent months. Many have lost their jobs and insurance coverage and need our help to stay on their medications," said John C. Lechleiter, Ph.D., Eli Lilly and Company chairman, president and chief executive officer. "Patients are our first priority. By relaxing the income guidelines for Lilly's patient assistance programs, more patients will qualify for Lilly's patient assistance programs."

The income eligibility adjustment is a long-term change for the programs, which over the past three years have assisted more than 580,000 patients in the United States and distributed medications valued at over $784 million.

Globally, over the past three years, Lilly has donated $883 million in products to patients and agencies throughout the world.

Patients who believe they qualify for any of Lilly's patient assistance programs, or whose financial situation has changed from their last tax filing
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Lilly Announces Continued Commitment to Transparency with Faculty Registry
2. Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
3. Lilly Receives Award From National Medical Association
4. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
5. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
6. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
7. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
8. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
9. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
10. Lilly Declares Third-Quarter Dividend
11. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market

Post Your Comments:

Lilly Broadens Income Eligibility for Patient Assistanc...( INDIANAPOLIS Aug. 5 /- In...),Health